Skip to main content
Skip to main content
Visit Teva Global website
Search
Investor Relations
News
Events and Presentations
Financials
Quarterly Results
Interactive Financials
SEC Filings
Debt Securities
Debt Factsheet
Sustainability-Linked Bonds
Shareholder Information
ADR Depositary Bank
Stock Quote & Chart
Dividends and Stock Splits
Shareholder Meetings
Environmental, Social and Governance
Corporate Officers
Board of Directors
Governance and Policy Documents
ESG Progress Report
Additional Resources
Analyst Coverage
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Epidemiology
Clinical Trial Appendix
Menu
Search
Close
Visit Teva Global website
News
Events and Presentations
Financials
Quarterly Results
Interactive Financials
SEC Filings
Debt Securities
Debt Factsheet
Sustainability-Linked Bonds
Shareholder Information
ADR Depositary Bank
Stock Quote & Chart
Dividends and Stock Splits
Shareholder Meetings
Environmental, Social and Governance
Corporate Officers
Board of Directors
Governance and Policy Documents
ESG Progress Report
Additional Resources
Analyst Coverage
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
Epidemiology
Clinical Trial Appendix
Home
Investors
>
Financials
>
SEC Filings
>
SEC Filings Details
SEC Filings Details
Form
8-K
Jan 12, 2026
Current report filing
PDF Format Download (opens in new window)
Excel Format Download (opens in new window)
XBRL Format Download (opens in new window)
XBRL Format Download (opens in new window)